CMS is rolling out new models for end-stage renal disease that look to improve care and quality of life, while simultaneously realizing savings.
"It's a big deal to be able to have this option," says David Whitley, MD, vascular surgeon at The Vascular Institute of Birmingham, and the first in the region to perform percutaneous creation of an arteriovenous fistula (AVF) in a patient using the Ellipsys device made by Avenu Medical.
If you ask Rebecca Harrison, RN and her aunt, Sue Gravelle, RN, about sacrifice, they will each point to the other. But last November, Harrison put her life on hold--and at risk--to give one of her kidneys to Gravelle.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: